Didier Trono

Summary

Affiliation: University of Geneva
Country: Switzerland

Publications

  1. ncbi Virology. Picking the right spot
    Didier Trono
    Department of Genetics and Microbiology, University of Geneva, Switzerland
    Science 300:1670-1. 2003
  2. ncbi Retroviruses under editing crossfire: a second member of the human APOBEC3 family is a Vif-blockable innate antiretroviral factor
    Didier Trono
    Department of Microbiology and Molecular Medicine, University of Geneva, CMU, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland
    EMBO Rep 5:679-80. 2004
  3. ncbi Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats
    Tuan Huy Nguyen
    Department of Microbiology and Molecular Medicine, CMU, University of Geneva, CH-1211 Geneva, Switzerland
    Mol Ther 12:852-9. 2005
  4. ncbi Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice
    Mike Themis
    Gene Therapy Research Group, Section of Cell and Molecular Biology, Imperial College London, UK
    Mol Ther 12:763-71. 2005
  5. ncbi Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells
    Els Verhoeyen
    INSERM, U412, Lyon, France
    Blood 106:3386-95. 2005
  6. ncbi Lentiviral vectors and antiretroviral intrinsic immunity
    Bastien Mangeat
    School of Life Sciences and Frontiers in Genetics National Center for Competence in Research, Swiss Federal Institute of Technology, Lausanne, Switzerland
    Hum Gene Ther 16:913-20. 2005
  7. ncbi Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors
    Krisztian Kvell
    Division of Hematology, Department of Internal Medicine, University Hospitals, 1211 Geneva 14, Switzerland
    Mol Ther 12:892-9. 2005
  8. ncbi Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond-blackfan anemia using inducible expression of siRNA against RPS19
    Koichi Miyake
    Molecular Medicine and Gene Therapy, Lund University, BMC A12, 221 84 Lund, Sweden
    Mol Ther 11:627-37. 2005
  9. ncbi Editing at the crossroad of innate and adaptive immunity
    Priscilla Turelli
    School of Life Sciences, , CH-1015 Lausanne, Switzerland
    Science 307:1061-5. 2005
  10. ncbi DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration
    Yasuo Ariumi
    Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211, Geneva 4, Switzerland
    J Virol 79:2973-8. 2005

Collaborators

Detail Information

Publications62

  1. ncbi Virology. Picking the right spot
    Didier Trono
    Department of Genetics and Microbiology, University of Geneva, Switzerland
    Science 300:1670-1. 2003
  2. ncbi Retroviruses under editing crossfire: a second member of the human APOBEC3 family is a Vif-blockable innate antiretroviral factor
    Didier Trono
    Department of Microbiology and Molecular Medicine, University of Geneva, CMU, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland
    EMBO Rep 5:679-80. 2004
  3. ncbi Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats
    Tuan Huy Nguyen
    Department of Microbiology and Molecular Medicine, CMU, University of Geneva, CH-1211 Geneva, Switzerland
    Mol Ther 12:852-9. 2005
    ..This work represents the first demonstration of a complete and permanent correction of hyperbilirubinemia in Gunn rats using lentiviral vectors...
  4. ncbi Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice
    Mike Themis
    Gene Therapy Research Group, Section of Cell and Molecular Biology, Imperial College London, UK
    Mol Ther 12:763-71. 2005
    ..This system may provide a highly sensitive model to investigate integrating vector safety prior to clinical application...
  5. ncbi Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells
    Els Verhoeyen
    INSERM, U412, Lyon, France
    Blood 106:3386-95. 2005
    ..This was demonstrated by their capacity to promote selective transduction of CD34(+) cell in in vitro derived long-term culture-initiating cell (LTC-IC) colonies and of long-term NOD/SCID repopulating cells (SRCs) in vivo...
  6. ncbi Lentiviral vectors and antiretroviral intrinsic immunity
    Bastien Mangeat
    School of Life Sciences and Frontiers in Genetics National Center for Competence in Research, Swiss Federal Institute of Technology, Lausanne, Switzerland
    Hum Gene Ther 16:913-20. 2005
    ..We present here the current state of knowledge on this rapidly evolving field and discuss implications for gene therapy...
  7. ncbi Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors
    Krisztian Kvell
    Division of Hematology, Department of Internal Medicine, University Hospitals, 1211 Geneva 14, Switzerland
    Mol Ther 12:892-9. 2005
    ..This system should be useful for gene function research in primary B cells and development of gene therapies...
  8. ncbi Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond-blackfan anemia using inducible expression of siRNA against RPS19
    Koichi Miyake
    Molecular Medicine and Gene Therapy, Lund University, BMC A12, 221 84 Lund, Sweden
    Mol Ther 11:627-37. 2005
    ..These novel cell lines represent models for RPS19-deficient DBA and can be used to identify the molecular mechanisms in RPS19-deficient DBA...
  9. ncbi Editing at the crossroad of innate and adaptive immunity
    Priscilla Turelli
    School of Life Sciences, , CH-1015 Lausanne, Switzerland
    Science 307:1061-5. 2005
    ..Exciting questions are raised, which take us to the depth of the intimate relations between vertebrates and the microbial underworld...
  10. ncbi DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration
    Yasuo Ariumi
    Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211, Geneva 4, Switzerland
    J Virol 79:2973-8. 2005
    ..We conclude that the DNA repair enzymes ATM, ATR, DNA-PKcs, and PARP-1 are not essential for HIV-1 integration...
  11. ncbi Harnessing HIV for therapy, basic research and biotechnology
    Maciej Wiznerowicz
    Frontiers in Genetics, National Center for Competence in Research, School of Life Sciences, Swiss Federal Institute of Technology, Laussane, Switzerland
    Trends Biotechnol 23:42-7. 2005
    ....
  12. ncbi Genotypic features of lentivirus transgenic mice
    Marc Olivier Sauvain
    Ecole Polytechnique Federale de Lausanne, School of Life Sciences, Lausanne CH 1015, Switzerland
    J Virol 82:7111-9. 2008
    ....
  13. ncbi Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes
    Tuan Huy Nguyen
    Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland
    J Hepatol 43:1031-7. 2005
    ..CONCLUSIONS: Lentiviral vectors represent tools of choice for immortalization of non-dividing primary cells, and lentivirally immortalized human hepatocytes are promising reagents for cell-based therapy of acute liver failure...
  14. ncbi A simple and highly effective method for the stable transduction of uncultured porcine hepatocytes using lentiviral vector
    Tuan Huy Nguyen
    Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Switzerland
    Cell Transplant 14:489-96. 2005
    ..We demonstrated that porcine hepatocytes are highly susceptible to lentiviral vector and describe an easy methodology to efficiently, rapidly, and stably introduce transgenes into uncultured porcine hepatocytes...
  15. ncbi Production and titration of lentiviral vectors
    Patrick Salmon
    Department of Neuroscience, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    Curr Protoc Hum Genet . 2007
    ..This unit also describes protocols for production and titration of LVs that can be implemented in a research laboratory setting, with an emphasis on standardization to improve transposability of results between laboratories...
  16. ncbi Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha
    Pierre V Maillard
    Global Health Institute, School of Life Sciences, Frontiers in Genetics National Center for Competence in Research, Ecole Polytechnique Federale de Lausanne EPFL, Lausanne, Switzerland
    PLoS Pathog 3:e200. 2007
    ....
  17. ncbi The Kruppel-associated box repressor domain can trigger de novo promoter methylation during mouse early embryogenesis
    Maciej Wiznerowicz
    School of Life Sciences, Frontiers in Genetics National Center for Competence in Research, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland
    J Biol Chem 282:34535-41. 2007
    ..Here we reveal that, in sharp contrast, KRAB-mediated repression results in irreversible gene silencing through promoter DNA methylation if it acts during the first few days of mouse development...
  18. ncbi Expression of FGF-2 in neural progenitor cells enhances their potential for cellular brain repair in the rodent cortex
    Alexandre G Dayer
    Department of Neurosciences, University Medical Center, University of Geneva Medical School, Geneva, Switzerland
    Brain 130:2962-76. 2007
    ....
  19. ncbi Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons
    Stephanie Jost
    School of Life Sciences and Frontiers in Genetics National Center for Competence in Research, Ecole Polytechnique Federale de Lausanne EPFL, CH 1015 Lausanne, Switzerland
    J Virol 81:10588-96. 2007
    ..We conclude that these cytidine deaminases are not essential effectors of IFN in its action against this pathogen...
  20. ncbi Inhibition of HIV-1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping
    Maria B Asparuhova
    Institute of Cell Biology, University of Bern, Baltzerstrasse 4, 3012 Bern, Switzerland
    J Gene Med 9:323-34. 2007
    ..Therefore, this new approach targeting HIV-1 regulatory genes at the level of pre-mRNA splicing, in combination with other antiviral strategies, may be a useful new tool in the fight against HIV/AIDS...
  21. ncbi Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat
    Tuan Huy Nguyen
    Department of Microbiology and Molecular Medicine, University of Geneva Medical Center, Geneva, Switzerland, and Service de biochimie, Hopital Saint Joseph, Paris, France
    Transplantation 82:794-803. 2006
    ..Here, we evaluated the SLIT approach in Gunn rats, the animal model for Crigler-Najjar syndrome type 1, a defect in bilirubin UDP-glucuronosyltransferase (BUGT)...
  22. ncbi KRAB can repress lentivirus proviral transcription independently of integration site
    Yannick Bulliard
    School of Life Sciences, Ecole Polytechnique Federale de Lausanne, CH 1015 Lausanne, Switzerland
    J Biol Chem 281:35742-6. 2006
    ..These results indicate that KRAB-induced transcriptional repression is robust and active over a variety of genomic contexts that include at least the wide range of sites targeted by lentiviral integration...
  23. ncbi The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription
    Yasuo Ariumi
    Department of Microbiology and Molecular Medicine, University of Geneva and Frontiers in Genetics National Center for Competence in Research, Switzerland
    Retrovirology 3:47. 2006
    ..These results suggest that the incoming PICs might recruit INI1 to facilitate proviral transcription...
  24. ncbi A versatile tool for conditional gene expression and knockdown
    Jolanta Szulc
    School of Life Sciences, , CH-1015 Lausanne, Switzerland
    Nat Methods 3:109-16. 2006
    ..These results open up promising perspectives for basic or translational research and for the development of gene-based therapeutics...
  25. ncbi Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia
    Johan Flygare
    Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine and The Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
    Blood 105:4627-34. 2005
    ..This study shows for the first time that RPS19 silencing decreases the proliferative capacity of hematopoietic progenitors and leads to a defect in erythroid development...
  26. ncbi APOBEC3G genetic variants and their influence on the progression to AIDS
    Ping An
    Basic Research Program, SAIC Frederick, National Cancer Institute Frederick Cancer Research and Development Center, Frederick, MD 21702, USA
    J Virol 78:11070-6. 2004
    ..These studies suggest that there may be a modifying role of variants of APOBEC3G on HIV-1 disease progression that warrants further investigation...
  27. ncbi Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
    Bastien Mangeat
    Department of Genetics and Microbiology, University of Geneva, 1211 Geneva 4, Switzerland
    Nature 424:99-103. 2003
    ..We also find that APOBEC3G can act on a broad range of retroviruses in addition to HIV, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens...
  28. ncbi Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes
    Tuan Huy Nguyen
    Departments of Genetics and Microbiology, Faculty of Medicine, University of Geneva, Switzerland
    Mol Ther 6:199-209. 2002
    ..These results have immediate implications for the treatment of liver diseases by the transplantation of genetically modified hepatocytes, an approach that could be applied to a number of hereditary and acquired hepatic disorders...
  29. ncbi IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes
    Els Verhoeyen
    , , Lyon, France
    Blood 101:2167-74. 2003
    ..With adult naive T cells, preactivation with recombinant IL-7 was necessary for efficient gene transfer. Altogether, these results suggest that IL-7-displaying vectors could constitute interesting tools for T-cell-targeted gene therapy...
  30. ncbi Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
    Virginie Sandrin
    , U412 INSERM, IFR 74, , Lyon, France
    Blood 100:823-32. 2002
    ..Furthermore, as compared to vectors pseudotyped with other retroviral GPs or with VSV-G, RD114/TR-pseudotyped vectors showed augmented transduction of human and macaque primary blood lymphocytes and CD34+ cells...
  31. ncbi Transepithelial transport of HIV-1 by M cells is receptor-mediated
    Grigorios Fotopoulos
    Swiss Institute for Experimental Cancer Research and Institute of Biochemistry, University of Lausanne, CH 1066 Epalinges, Switzerland
    Proc Natl Acad Sci U S A 99:9410-4. 2002
    ..The follicle-associated epithelium covering human gut lymphoid follicles expresses CCR5, but not CXCR4, and lactosyl cerebroside, suggesting that HIV-1 infection may occur through M cells and enterocytes at these sites...
  32. ncbi Lentivirus-mediated transduction of connexin cDNAs shows level- and isoform-specific alterations in insulin secretion of primary pancreatic beta-cells
    David Caton
    Department of Morphology, University of Geneva Medical School, 1211 Geneva 4, Switzerland
    J Cell Sci 116:2285-94. 2003
    ....
  33. ncbi Differentiation of the RN33B cell line into forebrain projection neurons after transplantation into the neonatal rat brain
    Cecilia Lundberg
    Wallenberg Neuroscience Center, Lund University, S-221 84, Sweden
    Exp Neurol 175:370-87. 2002
    ....
  34. ncbi A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action
    Bastien Mangeat
    Department of Microbiology and Molecular Medicine and Frontiers in Genetics Research Program, CMU, 1 rue Michel Servet, 1211 Geneva 4, Switzerland
    J Biol Chem 279:14481-3. 2004
    ..Furthermore, we show that this phenotype correlates with the ability of Vif to bind APOBEC3G and interfere with its incorporation into virions. These results shed light on an important determinant of the tropism of primate lentiviruses...
  35. ncbi Inhibition of hepatitis B virus replication by APOBEC3G
    Priscilla Turelli
    Department of Microbiology and Molecular Medicine and Frontiers in Genetics Research Program, University of Geneva, Switzerland
    Science 303:1829. 2004
  36. ncbi Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors
    Fabrice Bovia
    Division of Hematology, Department of Medicine, University Hospital, Geneva, Switzerland
    Blood 101:1727-33. 2003
    ..In conclusion, HIV vectors are promising tools for studies of gene functions in primary human B cells and myeloma cells for the purposes of research and the development of gene therapies...
  37. ncbi Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide
    Marielle Maurice
    , , U412 INSERM, IFR 74 and ENS de Lyon, , 69364 Lyon Cedex 07, France
    Blood 99:2342-50. 2002
    ..Moreover these results provide a proof of concept for an approach that may have utility in various gene transfer applications, including in vivo gene delivery...
  38. ncbi Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis
    Niels-Bjarne Woods
    Department for Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine, Lund University, Sweden
    Blood 101:1284-9. 2003
    ..While this is efficient in terms of transduction and transgene expression, it may increase the risk of insertional mutagenesis...
  39. ncbi Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection
    Angela Ciuffi
    Institute of Microbiology, University of Lausanne, Switzerland
    J Virol 78:10747-54. 2004
    ..The phenotype of provirus transcription was stable over time, indicating that it represents a genetic trait...
  40. ncbi Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells
    Jean Francois Arrighi
    Department of Dermatology and Venereology, University Hospital of Geneva, 4 752, 24 Rue Micheli du Crest, 1211 Geneva, Switzerland
    J Virol 78:10848-55. 2004
    ..The present system should have broad applications for studying the function of DC-SIGN in the pathogenesis of HIV as well as other pathogens also recognized by this receptor...
  41. ncbi Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes
    Odile Ducrey-Rundquist
    Department of Genetics and Microbiology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    J Virol 76:9103-11. 2002
    ....
  42. ncbi Lentivirus as a tool for lineage-specific gene manipulations
    Anna Malashicheva
    Department of Developmental Biology, Max Planck Institute for Immunobiology, Freiburg, Germany
    Genesis 45:456-9. 2007
    ..This LV feature will allow modulations of gene expression in a lineage-specific manner, thus having significant applications in mouse functional genetics...
  43. ncbi The HIV-1 Nef protein and phagocyte NADPH oxidase activation
    Frederik Vilhardt
    Biology of Ageing Laboratory, Department of Geriatrics, Geneva University Hospitals, Switzerland
    J Biol Chem 277:42136-43. 2002
    ..Rac activation is not sufficient to stimulate the phagocyte NADPH oxidase; however, it markedly enhances the NADPH oxidase response to other stimuli...
  44. ncbi Antiprion prophylaxis by gene transfer of a soluble prion antagonist
    Nicolas Genoud
    Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland
    Am J Pathol 172:1287-96. 2008
    ..These results suggest that somatic gene transfer of prion antagonists may be effective for postexposure prophylaxis of prion diseases...
  45. ncbi Production and titration of lentiviral vectors
    Patrick Salmon
    Department of Neuroscience, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    Curr Protoc Neurosci . 2006
    ..This unit also describes protocols for production and titration of LVs that can be implemented in a research laboratory setting, with an emphasis on standardization to improve transposability of results between laboratories...
  46. ncbi APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice
    Priscilla Turelli
    Global Health Institute, School of Life Sciences and Frontiers in Genetics National Center for Competence in Research, Ecole Polytechnique Federale de Lausanne, CH 1015 Lausanne, Switzerland
    J Virol 82:6585-90. 2008
    ..We conclude that APOBEC3 is not an essential mediator of the IFN-mediated inhibition of HBV in vivo...
  47. ncbi A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus
    Felipe Diaz-Griffero
    Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA
    Virology 378:233-42. 2008
    ..Thus, the range of retroviruses restricted by human TRIM5alpha can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid...
  48. ncbi Lentiviral vectors interfering with virus-induced CD4 down-modulation potently block human immunodeficiency virus type 1 replication in primary lymphocytes
    Hang M Pham
    La Jolla Institute for Molecular Medicine, 4570 Executive Dr, Suite 100, San Diego, CA 92121, USA
    J Virol 78:13072-81. 2004
    ..The findings presented here provide proof-of-principle that approaches targeting the virus-induced CD4 down-modulation may constitute the basis for novel anti-HIV therapies...
  49. ncbi Tuning silence: conditional systems for RNA interference
    Maciej Wiznerowicz
    School of Life Sciences, National Center for Competence in Research, , CH-1015 Lausanne, Switzerland
    Nat Methods 3:682-8. 2006
    ..Here we summarize the state of the art of systems allowing for drug-controllable knockdown, and provide a description of their current and future applications...
  50. ncbi The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay
    Priscilla Turelli
    Department of Microbiology and Molecular Medicine, University of Geneva, 1211 4, Switzerland
    J Biol Chem 279:43371-3. 2004
    ..We used such an assay to demonstrate that APOBEC3G, which impairs the replication of exogenous retroelements, does not affect the replication of endogenous L1 retrotransposons...
  51. ncbi ARF1 regulates Nef-induced CD4 degradation
    Julien Faure
    Department of Biochemistry, University of Geneva, 1211 Geneva, Switzerland
    Curr Biol 14:1056-64. 2004
    ..The HIV Nef protein downregulates CD4 through sequential connection with clathrin-coated pits and the COP1 coatomer, resulting in accelerated endocytosis and lysosomal targeting...
  52. ncbi Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion
    Michael D Bobardt
    Department of Immunology, IMM-9, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
    J Virol 78:6567-84. 2004
    ....
  53. ncbi Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins
    Claire Arnaud
    Division of Cardiology, Foundation for Medical Research, Faculty of Medicine, Geneva University Hospital, Switzerland
    Arterioscler Thromb Vasc Biol 25:1231-6. 2005
    ..We further show that statins act via inhibition of STAT3 phosphorylation. These findings furnish new evidence for direct antiinflammatory properties of statins and provide new mechanistic insight into their clinical benefits...
  54. ncbi Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference
    Maciej Wiznerowicz
    Department of Genetics and Microbiology, CMU, Faculty of Medicine, University of Geneva, 1211 Geneva 4, Switzerland
    J Virol 77:8957-61. 2003
    ..As lentivirus vectors can stably transduce a wide variety of targets both in vitro and in vivo and can be used to generate transgenic animals, the present system should have broad applications...
  55. ncbi Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization
    Mireille Guyader
    Department of Genetics and Microbiology, University of Geneva, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland
    J Virol 76:10356-64. 2002
    ....
  56. ncbi Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes
    Gang Mai
    Surgical Research Unit, Department of Surgery, University Hospital Geneva, Switzerland
    Xenotransplantation 12:457-64. 2005
    ....
  57. ncbi Hide, shield and strike back: how HIV-infected cells avoid immune eradication
    B Matija Peterlin
    Department of Medicine, Rosalind Russell Medical Research Center, University of California, San Francisco, California 94143 0703, USA
    Nat Rev Immunol 3:97-107. 2003
    ..A better understanding of these strategies might lead to new approaches in the fight against AIDS...
  58. ncbi Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function
    Yasuo Ariumi
    Department of Microbiology and Molecular Medicine, University of Geneva, Switzerland
    J Virol 80:2445-52. 2006
    ..Altogether, these results indicate that ATM can positively influence HIV-1 Rev function...
  59. ncbi Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta
    Karim Nadra
    Center for Integrative Genomics, University of Lausanne, CH 1015 Lausanne, Switzerland
    Mol Cell Biol 26:3266-81. 2006
    ..Altogether, this important role of PPARbeta/delta in placenta development and giant cell differentiation should be considered when contemplating the potency of PPARbeta/delta agonist as therapeutic agents of broad application...
  60. ncbi Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets
    Michael Eberhardt
    Division for Endocrinology, Diabetes and Clinical Nutrition, Department of Research, University Hospital Basel, Switzerland
    Biochem Biophys Res Commun 345:1167-76. 2006
    ..In conclusion, cultured pancreatic islets contain nestin and Isl-1 positive mesenchymal stem cells with multipotential developmental capacity...
  61. ncbi Characterization of APOBEC3G binding to 7SL RNA
    Daniel Bach
    Global Health Institute, School of Life Sciences and Frontiers in Genetics, National Center for Competence in Research, Ecole Polytechnique Federale de Lausanne EPFL, CH 1015, Lausanne, Switzerland
    Retrovirology 5:54. 2008
    ..We thus conclude that 7SL RNA is not an essential mediator of the virion packaging of these antiviral cytidine deaminases...